文献速递血液透析通路

肥胖促使终末期肾病患者为达到血管通路成熟而接受二次手术

Obesity drives secondary procedures to achieve access maturation in end-stage renal disease.
PubMed 文献 · J Vasc Surg · 2023-08-18

该单中心回顾性研究纳入1999年1月至2019年12月共2311例首次自体动静脉瘘患者,按体重指数分为非肥胖、I级、II级和III级肥胖。结果显示随着肥胖级别升高,达到动静脉瘘成熟所需手术次数增加、早期血栓形成增多、3年二次通畅率降低,且每年所需二次干预次数显著增多。

要点

  • III级肥胖患者达到成熟所需手术比例为74%,II级为51%,I级为22%,非肥胖为34%。
  • III级肥胖3年二次通畅率为62±4%,II级为79±3%,I级为87±2%,非肥胖为93±4%。
  • III级肥胖每年二次干预次数为3.9次,II级为3.1次,I级为2.5次,非肥胖为1.4次。

核心结论

  • 随着肥胖级别升高,达到动静脉瘘成熟所需手术次数增加,且肥胖级别越高,通畅性和功能性越差。

研究设计与样本

  • 单中心回顾性综述,纳入10年间所有接受首次自体动静脉瘘(桡头、肱头及肱贵要)的患者,按体重指数分为非肥胖、I级、II级和III级肥胖。
  • 1999年1月至2019年12月共2311例患者,女性占67%,平均年龄61±15岁,其中桡头动静脉瘘占12%、肱头占53%、肱贵要占35%。
  • 非肥胖占41%,I级肥胖占29%,II级肥胖占19%,III级肥胖占11%;多数患者为糖尿病和西班牙裔。

主要发现

  • 30天主要不良心血管事件率在II级肥胖为0.20%、III级为0.50%,高于I级肥胖的0.15%和非肥胖的0.05%。
  • 30天并发症率在III级、II级、I级肥胖和非肥胖分别为0.5%、0.3%、0.2%和0.05%。
  • 早期血栓形成在II级肥胖为9%、III级为12%,显著高于I级肥胖的5%和非肥胖的3%。
  • 达到成熟所需手术次数在II级肥胖为51%、III级为74%,较I级肥胖的22%和非肥胖的34%增加两倍。
  • 3年二次通畅率在III级肥胖为62±4%、II级为79±3%,显著低于I级肥胖的87±2%和非肥胖的93±4%;每年二次干预次数在III级、II级、I级肥胖和非肥胖分别为3.9、3.1、2.5和1.4次。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Establishing long-term arteriovenous access is an important component in the long-term care of a patient with end-stage renal disease. The increasing frequency of obesity is reported to impact the access management of end-stage renal disease patients. This study aims to evaluate the outcomes of arteriovenous fistulae (AVF) in obese and nonobese patients. METHODS: A retrospective review of all patients over ten years with primary autogenous AVF (radiocephalic, brachiocephalic, and brachial-basilic) was undertaken at a single center. Patients were subcategorized by body mass index into nonobese, class I, II, and III obesity. Outcomes of maturation (successful progression to hemodialysis), reintervention, functional dialysis (continuous hemodialysis for 3 consecutive months), and patency were examined. RESULTS: From January 1999 to December 2019, 2311 patients (67% female; mean age, 61 ± 15 years) underwent primary AVF placement (12% radiocephalic, 53% brachiocephalic, and 35% brachial basilic). Forty-one percent were nonobese, 29% had class I obesity, 19% had class II obesity, and 11% had class III obesity. The majority of patients were diabetic and Hispanic. The 30-day major adverse cardiovascular event rate was elevated in class II (0.20%) and class III (0.50%) obesity compared with class I obesity (0.15%) and nonobese (0.05%). The 30-day morbidity rate was higher in all classes of obesity (0.5% vs0.3% vs 0.2% vs 0.05% for class III vs class II vs class I obesity and nonobese, respectively). Early thrombosis was significantly increased in class II (9%) and class III obesity (12%) compared with class I obesity (5%) and nonobese (3%). There was a two-fold increase in procedures to effect maturation in class II (51%) and class III (74%) obesity compared with class I obesity (22%) and nonobese (34%). Secondary patency at 3 years was significantly lower in class III (62 ± 4%) and class II (79 ± 3%) compared with class I obesity (87 ± 2%) and nonobese (93 ± 4%). All classes of obesity required significantly more secondary Interventions per year compared with nonobese (3.9 vs 3.1 vs 2.5 vs 1.4 secondary interventions per year for class III vs class II vs class I obesity and nonobese, respectively). CONCLUSIONS: Advancing obesity class is associated with an increased number of procedures to achieve AVF maturation and is associated with poorer patency and functionality as the category of obesity advances.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Yan Q, Davies MG. Obesity drives secondary procedures to achieve access maturation in end-stage renal disease. J Vasc Surg. 2023. PMID: 37597592. doi:10.1016/j.jvs.2023.08.102

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。